Schrodinger Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
13.7%projected annual EPS growth
Analyst Coverage
7analysts covering
FY EPS (est.)
-$1.83next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 4 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Annual Contract Value (ACV) Quarterly28.4MTarget: 218 million to 228 million
Hosted Software Revenue Contribution Quarterly0.3Target: Majority of software contracts transitioned to hosted agreements by 2028
Drug Discovery Revenue Quarterly22.9MTarget: 55 million to 65 million
Watch Items
- Hosted Software Transition Progress
- Clinical Pipeline Milestones (SGR-1505 and SGR-3515)
- Bunsen AI Co-Scientist Commercial Adoption
Research as of 20 Jun 2026